Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARRAY BIOPHARMA INC | 20,157 | reported | 01 Apr 2017 | tx 73+1,315,710−401,947 |
| Edgewise Therapeutics, Inc. | 12,312 | reported | 12 Aug 2025 | tx 105+1,215,413−654,548 |
| Nivalis Therapeutics, Inc. | 12,300 | reported | 12 Sept 2016 | tx 2+19,950 |
| KEYSTONE AUTOMOTIVE INDUSTRIES INC | 0 | reported | 12 Oct 2007 | tx 3+2,046−3,816 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Aug 2025 | SALE | Edgewise Therapeutics, Inc. | 2,098 | 13.39 USD | |
| 12 Aug 2025 | EXERCISE | Edgewise Therapeutics, Inc. | 5,781 | 0.00 USD | |
| 12 Aug 2025 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 26,875 | 0.00 USD | deriv |
| 12 Aug 2025 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 161,250 | 0.00 USD | deriv |
| 12 Aug 2025 | EXERCISE | Edgewise Therapeutics, Inc. | 5,781 | 0.00 USD | deriv |
| 02 May 2025 | SALE | Edgewise Therapeutics, Inc. | 1,930 | 16.45 USD | |
| 01 May 2025 | EXERCISE | Edgewise Therapeutics, Inc. | 5,209 | 0.00 USD | |
| 01 May 2025 | EXERCISE | Edgewise Therapeutics, Inc. | 5,209 | 0.00 USD | deriv |
| 23 Sept 2024 | EXERCISE | Edgewise Therapeutics, Inc. | 20,922 | 0.71 USD | |
| 23 Sept 2024 | SALE | Edgewise Therapeutics, Inc. | 20,922 | 27.63 USD | |
| 20 Sept 2024 | SALE | Edgewise Therapeutics, Inc. | 50,000 | 28.37 USD | |
| 20 Sept 2024 | EXERCISE | Edgewise Therapeutics, Inc. | 50,000 | 0.71 USD | |
| 20 Sept 2024 | EXERCISE | Edgewise Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 23 Sept 2024 | EXERCISE | Edgewise Therapeutics, Inc. | 20,922 | 0.00 USD | deriv |
| 12 Aug 2024 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 23,125 | 0.00 USD | deriv |
| 12 Aug 2024 | GRANT_AWARD | Edgewise Therapeutics, Inc. | 138,750 | 0.00 USD | deriv |
| 01 May 2024 | EXERCISE | Edgewise Therapeutics, Inc. | 5,208 | 0.00 USD | |
| 02 May 2024 | SALE | Edgewise Therapeutics, Inc. | 1,956 | 18.91 USD | |
| 01 May 2024 | EXERCISE | Edgewise Therapeutics, Inc. | 5,208 | 0.00 USD | deriv |
| 07 Feb 2024 | EXERCISE | Edgewise Therapeutics, Inc. | 17,993 | 1.93 USD | |
| 09 Feb 2024 | EXERCISE | Edgewise Therapeutics, Inc. | 8,029 | 1.93 USD | |
| 08 Feb 2024 | SALE | Edgewise Therapeutics, Inc. | 3,813 | 20.01 USD | |
| 08 Feb 2024 | EXERCISE | Edgewise Therapeutics, Inc. | 3,813 | 1.93 USD | |
| 09 Feb 2024 | SALE | Edgewise Therapeutics, Inc. | 8,029 | 20.01 USD | |
| 07 Feb 2024 | SALE | Edgewise Therapeutics, Inc. | 17,993 | 20.00 USD |